1.
Australas J Dermatol
; 63(2): e170-e173, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1861177
Subject(s)
Hypohidrosis , Urticaria , Danazol/therapeutic use , Humans , Hypohidrosis/diagnosis , Hypohidrosis/drug therapy , Rare Diseases
2.
BMJ Neurol Open
; 2(2): e000101, 2020.
Article
in English
| MEDLINE | ID: covidwho-1007300
ABSTRACT
COVID-19 is a significant global health burden. The pulmonary morbidity and mortality of COVID-19 is well described, however, there is mounting evidence of neurological manifestations of SARS-CoV-2, which may be of prognostic significance. This paper summarises the available evidence in order to provide clinicians with a concise summary of the peripheral and central neurological manifestations of COVID-19, discusses specific issues regarding the management of chronic neurological disease in the context of the pandemic, and provides a summary of the thrombotic implications of the disease for the neurologist.